Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Tropicamide may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Minims® Tropicamide contains a mydriatic and cycloplegic agent. It is used to enlarge the pupil of your eye and temporarily paralyse the lens. Your doctor or eye specialist may use it to examine your eye. 2. Before you use your eye drops Do not use these drops if
your eye drops The drops are for single use only and provided in single use Minims units, to treat both eyes if necessary. Once opened, use immediately. Discard any unused portion.
Dosage
The following side effects may occur:
your eye drops Keep out of the reach and sight of children. Do not use the eye drops after the expiry date which is stated on the overwrap of each unit and on the carton after the letters "EXP". The expiry date refers to the last day of that month. Do not store above 25°C. Do not freeze. Store in the original package in order to protect from light. The drops are for single use only and provided in single use Minims units, to treat both eyes if necessary. Once opened, use immediately. Discard any unused portion. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. Further information What do your eye drops contain
This medicine does not contain a preservative as it is a sterile single use unit. Contents of the pack Each carton contains 20 units. Marketing Authorisation Holders: Bausch & Lomb UK Ltd. 106 London Road – Kingston-upon-Thames – KT2 6TN – UK Manufacturer: Zone Industrielle de Ripotier 50 Avenue Jean Monnet 07200 Aubenas France This leaflet was last revised in: November 2023
Minims Tropicamide 1% w/v, Eye drops solution comes as eye drops. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Minims Tropicamide 1% w/v, Eye drops solution is tropicamide.
Medicines with the same active substance, strength and form include: Minims Tropicamide 0.5% w/v, Eye drops solution, Mydriacyl 1% eye drops, solution, Tropicamide 1% w/v eye drops, solution in single-dose container. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Minims Tropicamide 1% w/v, Eye drops solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
As a topical mydriatic and cycloplegic.
Adults (including the elderly):
1 drop followed by a second drop after an interval of 5 minutes. A further 1 drop may be instilled after 30 minutes, if required. Children:
At the discretion of the physician.
Do not use in patients with a known hypersensitivity to tropicamide. Tropicamide is contraindicated in narrow angle glaucoma and in eyes where the filtration angle is narrow, as an acute attack of angle closure glaucoma may be precipitated.
Use with caution in an inflamed eye, as hyperaemia greatly increases the rate of systemic absorption through the conjunctiva. Care should be exercised in small children. Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of drops via the naso-lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.)Tropicamide may cause increased intraocular pressure. The possibility of undiagnosed glaucoma should be considered in some patients, such as elderly patients. Determine the intraocular pressure and an estimation of the depth of the angle of the anterior chamber prior to initiation of therapy.
None known.
There is no evidence as to the drug's safety in human pregnancy, nor is there evidence from animal work that it is free from hazard. This product should only be used in pregnancy if considered essential by the physician.
Patient warning: Patients who receive a mydriatic may suffer from photophobia and this may impair their ability to drive under certain circumstances.
Transient stinging, dry mouth and blurred vision may occur following the use of this product.
Systemic effects from Minims Tropicamide are not expected. Should an overdose occur causing local effects, e.g. sustained mydriasis, pilocarpine or 0.25% w/v physostigmine should be applied.
Ask anything about Minims Tropicamide 1% w/v, Eye drops solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.